Brought to you by 
The Medicines Co. exercises option to buy the rest of Annovation
20 Sep 2017
Executive Summary
Exercising an option it received in 2012, The Medicines Co. acquired the remaining 64% of Annovation Biopharma Inc. (a private acute care firm focused on safer anesthetics) it didn't already own, for approximately $28.4mm up front, $26.3mm in clinical and regulatory earn-outs, and a low single-digit sales royalty on global net sales of Annovation's products for a certain period.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Acquisition of Private Biotech
- Includes Earnout
- Intra-Biotech Deal
- Partial Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
The Medicines Co. exercises option to buy the rest of Annovation
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice